Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Leukemia, Myelomonocytic, Chronic × Histamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelomonocytic, Chronic 1

Interventions

defactinib 1 decitabine and cedazuridine drug combination 1 cedazuridine 1 cc-486 1 aldesleukin 1 Histamine 1 Decitabine 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03040401 2017-12-19

A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML)

Vastra Gotaland Region

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡